Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 180

The DOI matches its Crossref record.

N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome

Kusunoki, Susumu, Chiba, Atsuro, Kon, Kazuo, Ando, Susumu, Arisawa, Kazuko, Tate, Asako, Kanazawa, Ichiro · 1994 · Annals of Neurology

Abstract

Serum antibodies against such major glycolipids as GM1, GD1b, and LM1 have been reported in patients in the acute phase of Guillain‐Barré syndrome (GBS). Because minor unidentified glycolipids also may be targets of antibodies in GBS sera, we assayed serum antibody against a crude ganglioside fraction using thin‐layer chromatogram immunostaining. Antibody activity was detected against a band that migrated just below GD1a in 6 of the 50 patients with GBS tested. Antibody titer, as determined by enzyme‐linked immunosorbent assay, decreased during the course of the disease. All 6 patients had suffered gastrointestinal infection before the neurological onset of GBS and showed low amplitudes for the compound muscle action potentials and normal or only slightly decreased nerve conduction velocities. Thin‐layer chromatogram immunostaining did not show this antibody activity in any of the 16 normal and 119 disease controls. The unidentified glycolipid was isolated by DEAE–Sephadex A‐25 column chromatography, sialidase treatment, and Iatrobeads column chromatography. Fast atom bombardment‐mass spectra showed it to be N‐acetyl‐galactosaminyl GD1a.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.410350510

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 180

Metadata

Authors
Kusunoki, S., Chiba, A., Kon, K., Ando, S., Arisawa, K., Tate, A., & Kanazawa, I.
Venue
Annals of Neurology
Publisher
Wiley
Published
1994-05
Volume
35
Issue
5
Pages
570-576
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2118206412
Cited by
180
References
0
FWCI
6.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome. https://app.cochat.ai/papers/10.1002/ana.410350510
The paper
Kusunoki, S., Chiba, A., Kon, K., Ando, S., Arisawa, K., Tate, A., & Kanazawa, I. (1994). N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome. Annals of Neurology. https://doi.org/10.1002/ana.410350510

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.